docetaxel anhydrous has been researched along with n-caproylsphingosine in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (n-caproylsphingosine) | Trials (n-caproylsphingosine) | Recent Studies (post-2010) (n-caproylsphingosine) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 176 | 0 | 60 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, C; Dong, WL; Tian, Y; Wang, XF; Yang, L; Zhang, XY; Zhang, ZQ; Zheng, LY | 1 |
1 other study(ies) available for docetaxel anhydrous and n-caproylsphingosine
Article | Year |
---|---|
C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: a mechanism study.
Topics: Adenylate Kinase; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Ceramides; Cisplatin; Docetaxel; Drug Synergism; ErbB Receptors; Female; HEK293 Cells; Humans; Hydroxamic Acids; MAP Kinase Kinase 4; MCF-7 Cells; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Paclitaxel; Proteolysis; Taxoids; TOR Serine-Threonine Kinases; Vorinostat | 2015 |